Impact of initiating insulin glargine disposable pen vs vial/syringe on real‐world glycemic outcomes and persistence among patients with T2DM in a large managed care plan: A claims database analysis

Abstract Authors: Xie L, Zhou S, Pinsky BW, Buysman EK, Baser O. Background: Diabetes accounts for almost 15% of all direct healthcare expenditures. Managed care organizations try to reduce costs and improve patient outcomes. Increasing patient persistence with...